Clinical Trial Update: Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality [Phase 4]

View source ↗

Summary

A multicenter Phase 4 randomized trial is evaluating whether Helicobacter pylori eradication plus pepsinogen testing can reduce gastric cancer mortality. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Gastritis
• Gastric Cancer
• Helicobacter Pylori Infection

Snippet

Sponsor: International Agency for Research on Cancer | Conditions: Helicobacter Pylori Infections, Atrophic Gastritis | Phase 4 | Status: RECRUITING